General Information of This Drug (ID: DM6BGJ9)

Drug Name
BFF-122   DM6BGJ9
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Preclinical Indication(s)
Indication Name Indication ID ICD-11 Status REF
Schizophrenia DISSRV2N 6A20 Preclinical [1]
Cognitive impairment DISH2ERD 6D71 Preclinical [1]
------------------------------------------------------------------------------------

References

1 Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019 May;18(5):379-401.